Apritech 125/80 Capsule
Marketer
Uvtech Biosciences Private Limited
Salt Composition
Aprepitant (125mg) + Aprepitant (80mg)
Overview Apritech 125/80 Capsule
Ondansetron 125/80 mg capsules are a prescription medication combating chemotherapy-induced nausea and vomiting. This medication works by blocking the signals to the brain responsible for these symptoms. Dosage and duration for Ondansetron 125/80 mg capsules should strictly follow your physician's instructions, tailored to your individual needs and response. Complete the prescribed course; premature discontinuation may lead to symptom recurrence and potential condition exacerbation. Inform your doctor of all other medications you are using, as interactions are possible. Common side effects include constipation, dyspepsia, headache, fatigue, anorexia, and hiccups – usually temporary and self-resolving. Report any concerning side effects promptly. Drowsiness and dizziness are possible; avoid driving or activities requiring alertness until the effects are known. Alcohol should be avoided due to potential additive sedative effects. Disclose pregnancy, pregnancy intentions, or breastfeeding before commencing treatment.
Primary Ingredients of Apritech 125/80 Capsule
There is no text provided to rephrase.
Uses of Apritech 125/80 Capsule
Chemotherapy-induced emesis
Major Benefits of Apritech 125/80 Capsule:
Follow your doctor's instructions precisely regarding dosage and treatment length for Apritech 125/80 Capsules. These capsules can be ingested with or without food, although consistent timing is recommended.
Common Side effects of Apritech 125/80 Capsule:
- Constipation
- Indigestion
- Headache
- Tiredness
- Loss of appetite
- Hiccup
- Increased liver enzymes
How to use Apritech 125/80 Capsule:
Follow your doctor's instructions precisely regarding dosage and treatment length for Apritech 125/80 Capsules. These capsules can be ingested with or without food, however, consistent timing is recommended.
How Apritech 125/80 Capsule works:
Each Apritech 125/80 capsule contains a dual dose of aprepitant, counteracting a neurotransmitter responsible for chemotherapy-induced nausea and vomiting.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
The interaction of Apritech 125/80 Capsule with alcohol is undetermined. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Data on Apritech 125/80 Capsule use in pregnancy is lacking. Seek medical advice from your physician.
Breast feedingCONSULT YOUR DOCTOR
Use of Apritech 125/80 Capsules while breastfeeding is likely inadvisable. Preliminary research indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Using Apritech 125/80 Capsules might reduce awareness, impair vision, and cause drowsiness or dizziness. Driving is inadvisable if these effects are experienced.
KidneySAFE IF PRESCRIBED
The use of Apritech 125/80 Capsules is considered safe for individuals with kidney impairment. No modification to the Apritech 125/80 Capsule dosage is necessary.
LiverSAFE IF PRESCRIBED
The use of Apritech 125/80 Capsules in individuals with liver impairment appears to pose minimal risk. Current evidence indicates dose modification may be unnecessary, however, physician consultation is recommended.
What if you forget to take Apritech 125/80 Capsule :
Should you forget a dose of Apritech 125/80 Capsule, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Apritech 125/80 Capsule
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Gastrointestinal system |
3,018 People bought this recently